首页 > 最新文献

American Journal of Kidney Diseases最新文献

英文 中文
Health-Related Quality of Life After Living Kidney Donation: Insights From a Contemporary Meta-Analysis 活体肾脏捐献后健康相关生活质量:来自当代荟萃分析的见解
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-20 DOI: 10.1053/j.ajkd.2025.11.002
Neetika Garg , Carrie Thiessen , Didier A. Mandelbrot
{"title":"Health-Related Quality of Life After Living Kidney Donation: Insights From a Contemporary Meta-Analysis","authors":"Neetika Garg , Carrie Thiessen , Didier A. Mandelbrot","doi":"10.1053/j.ajkd.2025.11.002","DOIUrl":"10.1053/j.ajkd.2025.11.002","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 153-155"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145786058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-Related Quality of Life After Living Kidney Donation: A Systematic Review and Meta-Analysis 活体肾脏捐献后与健康相关的生活质量:系统回顾和荟萃分析
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-12 DOI: 10.1053/j.ajkd.2025.09.008
Stijn C. van de Laar , Hidde A. de Heus , Emma K. Massey , Liset H.M. Pengel , Robert J. Porte , Frank J.M.F. Dor , Robert C. Minnee
<div><h3>Rationale & Objective</h3><div>Living donor kidney transplantation is considered the most effective treatment for end-stage kidney disease, but healthy individuals who donate may experience potential threats to their long-term well-being. This meta-analysis assessed the impact of living kidney donation on health-related quality of life (HRQoL) among donors overall and among those at higher risk for negative health impacts.</div></div><div><h3>Study Design</h3><div>Systematic review and meta-analysis.</div></div><div><h3>Setting & Participants</h3><div>Living donors of kidney allografts included in studies of postdonation HRQoL with predefined inclusion and exclusion criteria. Studies were identified through a comprehensive search of Embase, MEDLINE OvidSP, CENTRAL, Web of Science, PsycINFO, and the top 100 rankings in Google Scholar.</div></div><div><h3>Data Extraction</h3><div>Data were extracted in accordance with PRISMA guidelines, with independent extraction by multiple observers to ensure accuracy.</div></div><div><h3>Analytical Approach</h3><div>Primary outcomes included the 36-item Short-Form Health Survey (SF-36) and its composite mental component summary (MCS) and physical component summary (PCS). These measures were used to compare postdonation HRQoL with predonation levels and to the HRQoL of the general population. Study-level effects were calculated as standardized mean differences for continuous variables. Pooled effects were estimated with a random-effects model using restricted maximum likelihood.</div></div><div><h3>Results</h3><div>The meta-analysis included 73 studies with 14,474 donors. The MCS did not show significant changes at 3, 6, or 12 or more months after donation compared with baseline. However, the PCS was significantly lower at 3 months after donation compared with before donation (standardized mean difference, −0.38 [95% CI, −0.72 to −0.05], <em>P</em> = 0.02), which did not persist at 6 or 12 months. Both PCS and MCS scores were significantly higher in donors than in the general population. Donors’ HRQoL scores were comparable to or better than those of healthy controls, recipients, patients who underwent a nephrectomy, and patients receiving maintenance dialysis.</div></div><div><h3>Limitations</h3><div>Heterogeneity in study populations and outcomes, a limited number of studies for certain comparisons, methodological weaknesses of especially older studies, variability across geographies studied, and unaccounted for temporal changes.</div></div><div><h3>Conclusions</h3><div>Kidney donors reported physical HRQoL to be decreased after living donor nephrectomy, which returned to predonation levels by 6 months. The HRQoL reported by living donors was significantly better than that of the general population and healthy controls. These findings suggest that concerns about postdonation HRQoL need not be a deterrent to potential living kidney donors.</div></div><div><h3>Trial Registration</h3><div>Registe
理由与目的活体肾脏移植(LDKT)被认为是治疗终末期肾脏疾病最有效的方法,但健康的捐赠者可能会对他们的长期健康造成潜在的威胁。本荟萃分析旨在评估活体肾脏捐赠(LDK)对供体总体和具有较高负面健康影响风险者健康相关生活质量(HRQoL)的影响。研究设计:系统评价和荟萃分析。环境与研究人群同种异体肾移植活体供者被纳入捐献后HRQoL的研究,具有预定义的纳入和排除标准。通过Embase、MEDLINE OvidSP、CENTRAL、Web of Science、PsycINFO和b谷歌Scholar排名前100的综合搜索来确定研究。数据提取按照PRISMA指南提取数据,由多个观测者独立提取以确保准确性。主要结果包括SF-36及其综合心理成分总结(MCS)和生理成分总结(PCS)。这些指标用于比较捐献后与捐献前的HRQoL水平以及与一般人群的HRQoL水平。研究水平效应以连续变量的标准化平均差异计算。用限制最大似然的随机效应模型估计合并效应。结果荟萃分析包括73项研究,14474名供体。与基线相比,捐献后3、6、12个月或更长时间的MCS确实显示出显著的变化。然而,与捐献前相比,捐献后3个月的PCS显著降低(SMD为-0.38;95% CI: -0.72至-0.05,p = 0.02),这种情况在6或12个月时不会持续。献血者的PCS和MCS评分明显高于一般人群。供者的HRQoL评分与健康对照者、受者、接受肾切除术的患者和接受维护性透析的患者相当或更好。局限性:研究人群和结果的异质性,某些比较的研究数量有限,特别是旧研究的方法学弱点,研究的地理差异,以及未解释的时间变化。结论肾供者报告活体肾切除术后HRQoL下降,6个月后恢复到捐献前水平。活体献血者报告的HRQoL明显优于普通人群和健康对照组。这些发现表明,对捐赠后HRQoL的担忧不必成为潜在活体肾脏捐赠者的威慑。
{"title":"Health-Related Quality of Life After Living Kidney Donation: A Systematic Review and Meta-Analysis","authors":"Stijn C. van de Laar ,&nbsp;Hidde A. de Heus ,&nbsp;Emma K. Massey ,&nbsp;Liset H.M. Pengel ,&nbsp;Robert J. Porte ,&nbsp;Frank J.M.F. Dor ,&nbsp;Robert C. Minnee","doi":"10.1053/j.ajkd.2025.09.008","DOIUrl":"10.1053/j.ajkd.2025.09.008","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Rationale &amp; Objective&lt;/h3&gt;&lt;div&gt;Living donor kidney transplantation is considered the most effective treatment for end-stage kidney disease, but healthy individuals who donate may experience potential threats to their long-term well-being. This meta-analysis assessed the impact of living kidney donation on health-related quality of life (HRQoL) among donors overall and among those at higher risk for negative health impacts.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;Systematic review and meta-analysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting &amp; Participants&lt;/h3&gt;&lt;div&gt;Living donors of kidney allografts included in studies of postdonation HRQoL with predefined inclusion and exclusion criteria. Studies were identified through a comprehensive search of Embase, MEDLINE OvidSP, CENTRAL, Web of Science, PsycINFO, and the top 100 rankings in Google Scholar.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Data Extraction&lt;/h3&gt;&lt;div&gt;Data were extracted in accordance with PRISMA guidelines, with independent extraction by multiple observers to ensure accuracy.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Analytical Approach&lt;/h3&gt;&lt;div&gt;Primary outcomes included the 36-item Short-Form Health Survey (SF-36) and its composite mental component summary (MCS) and physical component summary (PCS). These measures were used to compare postdonation HRQoL with predonation levels and to the HRQoL of the general population. Study-level effects were calculated as standardized mean differences for continuous variables. Pooled effects were estimated with a random-effects model using restricted maximum likelihood.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The meta-analysis included 73 studies with 14,474 donors. The MCS did not show significant changes at 3, 6, or 12 or more months after donation compared with baseline. However, the PCS was significantly lower at 3 months after donation compared with before donation (standardized mean difference, −0.38 [95% CI, −0.72 to −0.05], &lt;em&gt;P&lt;/em&gt; = 0.02), which did not persist at 6 or 12 months. Both PCS and MCS scores were significantly higher in donors than in the general population. Donors’ HRQoL scores were comparable to or better than those of healthy controls, recipients, patients who underwent a nephrectomy, and patients receiving maintenance dialysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Limitations&lt;/h3&gt;&lt;div&gt;Heterogeneity in study populations and outcomes, a limited number of studies for certain comparisons, methodological weaknesses of especially older studies, variability across geographies studied, and unaccounted for temporal changes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Kidney donors reported physical HRQoL to be decreased after living donor nephrectomy, which returned to predonation levels by 6 months. The HRQoL reported by living donors was significantly better than that of the general population and healthy controls. These findings suggest that concerns about postdonation HRQoL need not be a deterrent to potential living kidney donors.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Trial Registration&lt;/h3&gt;&lt;div&gt;Registe","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 159-181"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145516257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Home Dialysis Utilization in Puerto Rico 波多黎各家庭透析的使用情况。
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-12 DOI: 10.1053/j.ajkd.2025.07.017
Anthony Barisano , Daeho Kim , Rajnish Mehrotra , Amal N. Trivedi , Maricruz Rivera-Hernandez
{"title":"Home Dialysis Utilization in Puerto Rico","authors":"Anthony Barisano ,&nbsp;Daeho Kim ,&nbsp;Rajnish Mehrotra ,&nbsp;Amal N. Trivedi ,&nbsp;Maricruz Rivera-Hernandez","doi":"10.1053/j.ajkd.2025.07.017","DOIUrl":"10.1053/j.ajkd.2025.07.017","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 230-233"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145516258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise and Kidney Health: Core Curriculum 2026 运动与肾脏健康:核心课程2026。
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-13 DOI: 10.1053/j.ajkd.2025.09.014
Laura Aponte Becerra, Sherry G. Mansour
Exercise triggers complex effects on kidney physiology that vary with intensity, duration, and environmental conditions. While moderate physical activity improves cardiovascular and renal outcomes, intense or prolonged exertion, particularly in endurance sports, can lead to acute kidney injury. Adaptations in kidney physiology during exercise include reduced plasma flow, altered glomerular filtration, and hormone-mediated fluid retention. These changes are protective but may become maladaptive with dehydration, heat stress, or excessive fluid intake. High-intensity exercise increases oxidative stress and proteinuria, while ultramarathon participation may cause transient creatinine elevation from muscle breakdown, complicating acute kidney injury diagnosis. Prevention strategies include individualized hydration plans, electrolyte replacement, and avoidance of nonsteroidal anti-inflammatory drugs. In special populations, such as children with chronic kidney disease or patients receiving dialysis, structured exercise enhances quality of life and physical function when implemented safely. Clinicians must balance the benefits of exercise with kidney-related risks, promote safe training practices, and recognize early signs of exertional complications to optimize renal and overall health in physically active individuals. This core curriculum reviews the physiology of exercise on kidney function and provides evidence-based strategies for patient counseling and risk reduction.
运动对肾脏生理的复杂影响随强度、持续时间和环境条件的不同而变化。虽然适度的体育活动可以改善心血管和肾脏的预后,但剧烈或长时间的运动,特别是耐力运动,可能导致急性肾损伤。运动期间肾脏生理的适应包括血浆流量减少、肾小球滤过改变和激素介导的液体潴留。这些变化具有保护作用,但可能因脱水、热应激或摄入过多液体而变得不适应。高强度运动增加氧化应激和蛋白尿,而参加超级马拉松可能导致肌肉分解引起短暂的肌酐升高,使急性肾损伤诊断复杂化。预防策略包括个体化补水计划、电解质替代和避免使用非甾体类抗炎药。在特殊人群中,如患有慢性肾脏疾病的儿童或接受透析的患者,在安全的情况下,有组织的运动可以提高生活质量和身体功能。临床医生必须平衡运动的益处与肾脏相关的风险,促进安全的训练实践,并识别运动并发症的早期迹象,以优化运动个体的肾脏和整体健康。本核心课程回顾了运动对肾功能的生理影响,并为患者咨询和降低风险提供了循证策略。
{"title":"Exercise and Kidney Health: Core Curriculum 2026","authors":"Laura Aponte Becerra,&nbsp;Sherry G. Mansour","doi":"10.1053/j.ajkd.2025.09.014","DOIUrl":"10.1053/j.ajkd.2025.09.014","url":null,"abstract":"<div><div>Exercise triggers complex effects on kidney physiology that vary with intensity, duration, and environmental conditions. While moderate physical activity improves cardiovascular and renal outcomes, intense or prolonged exertion, particularly in endurance sports, can lead to acute kidney injury. Adaptations in kidney physiology during exercise include reduced plasma flow, altered glomerular filtration, and hormone-mediated fluid retention. These changes are protective but may become maladaptive with dehydration, heat stress, or excessive fluid intake. High-intensity exercise increases oxidative stress and proteinuria, while ultramarathon participation may cause transient creatinine elevation from muscle breakdown, complicating acute kidney injury diagnosis. Prevention strategies include individualized hydration plans, electrolyte replacement, and avoidance of nonsteroidal anti-inflammatory drugs. In special populations, such as children with chronic kidney disease or patients receiving dialysis, structured exercise enhances quality of life and physical function when implemented safely. Clinicians must balance the benefits of exercise with kidney-related risks, promote safe training practices, and recognize early signs of exertional complications to optimize renal and overall health in physically active individuals. This core curriculum reviews the physiology of exercise on kidney function and provides evidence-based strategies for patient counseling and risk reduction.</div></div>","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 246-259"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145732820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why This Research Matters 为什么这项研究很重要。
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-19 DOI: 10.1053/j.ajkd.2025.07.021
Robert Sanchez MPS
{"title":"Why This Research Matters","authors":"Robert Sanchez MPS","doi":"10.1053/j.ajkd.2025.07.021","DOIUrl":"10.1053/j.ajkd.2025.07.021","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages A8-A9"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145792907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Pain Locations, Characteristics, and Associations With Other Symptoms in Adults Receiving Maintenance Hemodialysis: Findings From the HOPE Consortium Trial 接受维持性血液透析的成人慢性疼痛的部位、特征和与其他症状的关联:来自HOPE联盟试验的发现
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-12 DOI: 10.1053/j.ajkd.2025.09.009
Michael J. Fischer , Jesse Y. Hsu , Joanna Walsh , Kerri L. Cavanaugh , David M. Charytan , Susan T. Crowley , Daniel Cukor , Laura M. Dember , Ardith Z. Doorenbos , Denise Esserman , Manisha Jhamb , Kirsten L. Johansen , Francis J. Keefe , Paul L. Kimmel , Mark B. Lockwood , Rajnish Mehrotra , Benjamin J. Morasco , Sagar Nigwekar , Patrick Pun , Rudy Qamhiyeh , Sahir Kalim
<div><h3>Rationale & Objective</h3><div>Adults receiving maintenance hemodialysis (HD) frequently report pain, yet detailed descriptions of pain in this population are lacking. This study examines pain locations, characteristics, and associations with other symptoms in adults receiving HD.</div></div><div><h3>Study Design</h3><div>Cross-sectional analysis.</div></div><div><h3>Setting & Participants</h3><div>Adults with moderate to severe chronic pain receiving maintenance HD enrolled in the multicenter HOPE Consortium Trial from 2021 to 2023.</div></div><div><h3>Exposure</h3><div>Sociodemographic, pain treatment, dialysis, medical comorbidity, and psychological and behavioral characteristics. Other patient-reported symptoms.</div></div><div><h3>Outcome</h3><div>Pain interference and severity as assessed by the Brief Pain Inventory (BPI) Interference and Severity subscales (range, 0-10).</div></div><div><h3>Analytical Approach</h3><div>Multivariable regression with least absolute shrinkage and selection operator (LASSO) to examine associations between participant characteristics and pain interference/severity, and Spearman’s correlation to examine relationships between other symptoms and pain interference/severity at baseline.</div></div><div><h3>Results</h3><div>Among 643 participants, the median BPI interference was 6.6 (IQR, 5.1-7.9) and severity was 6.0 (IQR, 4.5-7.5). Among the participants, 84% of participants reported pain >1 year, and 75% had daily pain; 89% and 66% of participants endorsed musculoskeletal and neuropathic pain, respectively. Of 32 body regions, the median number of painful regions was 8 (IQR, 4-14). Common regions in females were lower back (72%), knees (64%), legs (60%), and upper back (59%), and a similar pattern existed for males. In LASSO analyses, cardiovascular disease and depression were associated with significantly higher pain interference whereas White race (reference, Black race) and non-Hispanic ethnicity were associated with significantly lower pain interference. Similar findings were noted for pain severity. Pain catastrophizing and symptoms of fatigue, depression, and anxiety were moderately correlated with pain interference (<em>r</em> > 0.4).</div></div><div><h3>Limitations</h3><div>Neither relationship directionality nor causality can be inferred.</div></div><div><h3>Conclusions</h3><div>Among adults treated with HD who have chronic pain, pain locations were numerous and diverse, with substantial musculoskeletal and neuropathic characteristics. Factors associated with pain interference were predominantly sociodemographic and psychological rather than those related to comorbid diseases and dialysis.</div></div><div><h3>Plain-Language Summary</h3><div>Adults receiving maintenance hemodialysis (HD) frequently experience chronic pain, but it remains poorly understood. We examined pain locations, characteristics, and relationships with other symptoms among 643 adults with moderate to severe chron
理由与目的接受维持性血液透析(HD)的成年人经常报告疼痛,但缺乏对这一人群疼痛的详细描述。本研究探讨成人HD患者的疼痛部位、特征及其与其他症状的关系。研究设计横断面分析。环境和参与者:接受维持性HD治疗的中度至重度慢性疼痛的成人纳入2021 - 2023年多中心HOPE联合试验。暴露因素:社会人口统计学、疼痛治疗、透析、医疗合并症、心理和行为特征。其他患者报告的症状。结果疼痛干扰和严重程度由简短疼痛量表(BPI)干扰和严重程度量表评估(范围0-10)。分析方法:采用LASSO进行多变量回归,以检验受试者特征与疼痛干扰/严重程度之间的关系;采用Spearman相关,以检验基线时其他症状与疼痛干扰/严重程度之间的关系。结果643名参与者中位(IQR) BPI干扰为6.6(5.1-7.9),严重程度为6.0(4.5-7.5)。84%的参与者报告疼痛持续了10年,75%的人每天都有疼痛。89%和66%的参与者分别认可肌肉骨骼和神经性疼痛。32个身体区域中,疼痛区域的中位数(IQR)为8(4-14)。女性常见部位为下背部(72%)、膝盖(64%)、腿部(60%)和上背部(59%)。男性也存在类似的模式。在LASSO分析中,心血管疾病和抑郁症与明显较高的疼痛干扰相关,而白人种族(参考:黑人种族)和非西班牙裔种族与明显较低的疼痛干扰相关。在疼痛严重程度上也有类似的发现。疼痛灾难化和疲劳、抑郁、焦虑症状与疼痛干扰有中度相关性(r = 0.40)。局限性:关系、方向性和因果性都不能推断出来。结论在患有慢性疼痛的成人HD患者中,疼痛部位多种多样,具有明显的肌肉骨骼和神经病变特征。与疼痛干扰相关的因素主要是社会人口学和心理因素,而不是与合并症和透析相关的因素。
{"title":"Chronic Pain Locations, Characteristics, and Associations With Other Symptoms in Adults Receiving Maintenance Hemodialysis: Findings From the HOPE Consortium Trial","authors":"Michael J. Fischer ,&nbsp;Jesse Y. Hsu ,&nbsp;Joanna Walsh ,&nbsp;Kerri L. Cavanaugh ,&nbsp;David M. Charytan ,&nbsp;Susan T. Crowley ,&nbsp;Daniel Cukor ,&nbsp;Laura M. Dember ,&nbsp;Ardith Z. Doorenbos ,&nbsp;Denise Esserman ,&nbsp;Manisha Jhamb ,&nbsp;Kirsten L. Johansen ,&nbsp;Francis J. Keefe ,&nbsp;Paul L. Kimmel ,&nbsp;Mark B. Lockwood ,&nbsp;Rajnish Mehrotra ,&nbsp;Benjamin J. Morasco ,&nbsp;Sagar Nigwekar ,&nbsp;Patrick Pun ,&nbsp;Rudy Qamhiyeh ,&nbsp;Sahir Kalim","doi":"10.1053/j.ajkd.2025.09.009","DOIUrl":"10.1053/j.ajkd.2025.09.009","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Rationale &amp; Objective&lt;/h3&gt;&lt;div&gt;Adults receiving maintenance hemodialysis (HD) frequently report pain, yet detailed descriptions of pain in this population are lacking. This study examines pain locations, characteristics, and associations with other symptoms in adults receiving HD.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;Cross-sectional analysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting &amp; Participants&lt;/h3&gt;&lt;div&gt;Adults with moderate to severe chronic pain receiving maintenance HD enrolled in the multicenter HOPE Consortium Trial from 2021 to 2023.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Exposure&lt;/h3&gt;&lt;div&gt;Sociodemographic, pain treatment, dialysis, medical comorbidity, and psychological and behavioral characteristics. Other patient-reported symptoms.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Outcome&lt;/h3&gt;&lt;div&gt;Pain interference and severity as assessed by the Brief Pain Inventory (BPI) Interference and Severity subscales (range, 0-10).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Analytical Approach&lt;/h3&gt;&lt;div&gt;Multivariable regression with least absolute shrinkage and selection operator (LASSO) to examine associations between participant characteristics and pain interference/severity, and Spearman’s correlation to examine relationships between other symptoms and pain interference/severity at baseline.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Among 643 participants, the median BPI interference was 6.6 (IQR, 5.1-7.9) and severity was 6.0 (IQR, 4.5-7.5). Among the participants, 84% of participants reported pain &gt;1 year, and 75% had daily pain; 89% and 66% of participants endorsed musculoskeletal and neuropathic pain, respectively. Of 32 body regions, the median number of painful regions was 8 (IQR, 4-14). Common regions in females were lower back (72%), knees (64%), legs (60%), and upper back (59%), and a similar pattern existed for males. In LASSO analyses, cardiovascular disease and depression were associated with significantly higher pain interference whereas White race (reference, Black race) and non-Hispanic ethnicity were associated with significantly lower pain interference. Similar findings were noted for pain severity. Pain catastrophizing and symptoms of fatigue, depression, and anxiety were moderately correlated with pain interference (&lt;em&gt;r&lt;/em&gt; &gt; 0.4).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Limitations&lt;/h3&gt;&lt;div&gt;Neither relationship directionality nor causality can be inferred.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Among adults treated with HD who have chronic pain, pain locations were numerous and diverse, with substantial musculoskeletal and neuropathic characteristics. Factors associated with pain interference were predominantly sociodemographic and psychological rather than those related to comorbid diseases and dialysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Plain-Language Summary&lt;/h3&gt;&lt;div&gt;Adults receiving maintenance hemodialysis (HD) frequently experience chronic pain, but it remains poorly understood. We examined pain locations, characteristics, and relationships with other symptoms among 643 adults with moderate to severe chron","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 182-198.e1"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145516261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are Mother Glomeruli in Good or Bad Company? 母肾小球是好还是坏?
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-29 DOI: 10.1053/j.ajkd.2025.10.008
Georgina Gyarmati
{"title":"Are Mother Glomeruli in Good or Bad Company?","authors":"Georgina Gyarmati","doi":"10.1053/j.ajkd.2025.10.008","DOIUrl":"10.1053/j.ajkd.2025.10.008","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 275-277"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Reply to “Low-Flow Home Hemodialysis Technologies: The Key to Greener Dialysis?” 回复“低流量家庭血液透析技术:绿色透析的关键?”
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-05 DOI: 10.1053/j.ajkd.2025.10.010
Katherine A. Barraclough PhD , Ben Talbot PhD , Scott McAlister PhD
{"title":"In Reply to “Low-Flow Home Hemodialysis Technologies: The Key to Greener Dialysis?”","authors":"Katherine A. Barraclough PhD ,&nbsp;Ben Talbot PhD ,&nbsp;Scott McAlister PhD","doi":"10.1053/j.ajkd.2025.10.010","DOIUrl":"10.1053/j.ajkd.2025.10.010","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 284-285"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selecting Antihypertensive Medications for Kidney Transplant Recipients: Flying Blind 为肾移植受者选择抗高血压药物:盲目飞行。
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-04 DOI: 10.1053/j.ajkd.2025.09.016
Deepthi Malepati, Paul E. Drawz
{"title":"Selecting Antihypertensive Medications for Kidney Transplant Recipients: Flying Blind","authors":"Deepthi Malepati,&nbsp;Paul E. Drawz","doi":"10.1053/j.ajkd.2025.09.016","DOIUrl":"10.1053/j.ajkd.2025.09.016","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 272-274"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Access to Kidney Transplantation in Adults With Severe Obesity: A Population-Based Retrospective Cohort Study 重度肥胖成人肾移植:一项基于人群的回顾性队列研究
IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-12 DOI: 10.1053/j.ajkd.2025.09.013
Natasha Wiebe , Stephanie Thompson , Ashley Spellman , Ngan N. Lam , Marcello Tonelli
<div><h3>Rationale & Objective</h3><div>International guidelines do not consider moderate or severe obesity to be a contraindication to kidney transplantation, but clinical practice suggests otherwise. This study evaluated the likelihood of kidney transplantation in patients with moderate or severe obesity and how that likelihood compared with patients with other risk factors.</div></div><div><h3>Study Design</h3><div>Retrospective population-based cohort study.</div></div><div><h3>Setting & Participants</h3><div>96,181 adults with kidney failure, living in Canada between 2000 and 2021.</div></div><div><h3>Exposure</h3><div>Moderate or severe obesity and other risk factors (eg, age groups, diabetes, heart disease).</div></div><div><h3>Outcome</h3><div>Time to transplantation and time to allograft failure or death.</div></div><div><h3>Analytical Approach</h3><div>Parametric survival modeling, adjusting for all risk factors.</div></div><div><h3>Results</h3><div>Over a median follow-up period of 2.5 years, 58.2% of patients died, and 16.3% were transplanted. Participants with severe (body mass index [BMI] ≥ 40 kg/m<sup>2</sup>) or moderate (BMI 35.0-39.9 kg/m<sup>2</sup>) obesity were less likely to be transplanted than the control participants (BMI 18.5-24.9 kg/m<sup>2</sup>) (HR, 0.43 [95% CI, 0.39-0.47] and HR, 0.76 [95% CI, 0.71-0.82], respectively). Of 39 characteristics/categories considered, only participants aged ≥80 years were less likely to receive a transplant than those with severe obesity. Transplant recipients were followed for a median of 5.4 years. After those aged ≥65 years, participants with severe obesity were the most likely to experience allograft failure or death (HR, 1.70 [95% CI, 1.38-2.02] compared with controls). When we considered combinations of key risk factors, young participants with severe or moderate obesity and few comorbidities were at lower risk for allograft failure or death than participants with other common clinical characteristics.</div></div><div><h3>Limitations</h3><div>Residual confounding.</div></div><div><h3>Conclusions</h3><div>Canadian dialysis patients with moderate or severe obesity had a markedly reduced likelihood of receiving a kidney transplant. Although patients with moderate or severe obesity also had a heightened risk of allograft failure or death, the magnitude of the latter was similar to the excess risk associated with other common clinical characteristics. These findings support current practice guidelines and suggest that further work should identify and remove barriers to accessing kidney transplantation among patients with obesity.</div></div><div><h3>Plain-Language Summary</h3><div>International guidelines do not consider moderate or severe obesity (body mass index ≥35 and ≥40 kg/m<sup>2</sup>, respectively) to be a contraindication to kidney transplantation, but clinical practice suggests otherwise. Canadian dialysis patients with moderate or severe obesity had a reduced likel
理由与目的国际指南不认为中度或重度肥胖是肾移植的禁忌症,但临床实践表明并非如此。本研究旨在评估中度或重度肥胖患者进行肾移植的可能性,并将其与具有其他危险因素的患者进行比较。研究设计:基于人群的回顾性队列研究。环境和参与者:2000年至2021年期间居住在加拿大的96,181名肾功能衰竭成年人。暴露程度中度或重度肥胖及其他危险因素(例如,年龄组、糖尿病、心脏病)。结果:移植时间,移植失败或死亡时间。分析方法参数生存模型,调整所有风险因素。结果在中位随访2.5年期间,58.2%的患者死亡,16.3%的患者移植。重度肥胖(BMI≥40 kg/m2)或中度肥胖(BMI 35.0-39.9 kg/m2)的受试者移植的可能性低于对照组(BMI 18.5-24.9 kg/m2) (HR分别为0.43 [95% CI, 0.39-0.47]和0.76 [95% CI, 0.71-0.82])。在考虑的39个特征/类别中,只有年龄≥80岁的参与者接受移植的可能性低于严重肥胖的参与者。移植受者的随访时间中位数为5.4年。年龄≥65岁后,严重肥胖的参与者最有可能经历同种异体移植失败或死亡(与对照组相比,HR为1.70 [95% CI, 1.38-2.02])。当我们考虑关键危险因素的组合时,患有严重或中度肥胖且很少合并症的年轻参与者发生同种异体移植失败或死亡的风险低于具有其他常见临床特征的参与者。LIMITATIONSResidual混淆。结论:加拿大中度或重度肥胖的透析患者接受肾移植的可能性明显降低。虽然中度或重度肥胖患者也有较高的同种异体移植失败或死亡风险,但后者的程度与其他常见临床特征相关的过度风险相似。这些发现支持当前的实践指南,并建议进一步的工作应该确定和消除肥胖患者获得肾移植的障碍。
{"title":"Access to Kidney Transplantation in Adults With Severe Obesity: A Population-Based Retrospective Cohort Study","authors":"Natasha Wiebe ,&nbsp;Stephanie Thompson ,&nbsp;Ashley Spellman ,&nbsp;Ngan N. Lam ,&nbsp;Marcello Tonelli","doi":"10.1053/j.ajkd.2025.09.013","DOIUrl":"10.1053/j.ajkd.2025.09.013","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Rationale &amp; Objective&lt;/h3&gt;&lt;div&gt;International guidelines do not consider moderate or severe obesity to be a contraindication to kidney transplantation, but clinical practice suggests otherwise. This study evaluated the likelihood of kidney transplantation in patients with moderate or severe obesity and how that likelihood compared with patients with other risk factors.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;Retrospective population-based cohort study.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting &amp; Participants&lt;/h3&gt;&lt;div&gt;96,181 adults with kidney failure, living in Canada between 2000 and 2021.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Exposure&lt;/h3&gt;&lt;div&gt;Moderate or severe obesity and other risk factors (eg, age groups, diabetes, heart disease).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Outcome&lt;/h3&gt;&lt;div&gt;Time to transplantation and time to allograft failure or death.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Analytical Approach&lt;/h3&gt;&lt;div&gt;Parametric survival modeling, adjusting for all risk factors.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Over a median follow-up period of 2.5 years, 58.2% of patients died, and 16.3% were transplanted. Participants with severe (body mass index [BMI] ≥ 40 kg/m&lt;sup&gt;2&lt;/sup&gt;) or moderate (BMI 35.0-39.9 kg/m&lt;sup&gt;2&lt;/sup&gt;) obesity were less likely to be transplanted than the control participants (BMI 18.5-24.9 kg/m&lt;sup&gt;2&lt;/sup&gt;) (HR, 0.43 [95% CI, 0.39-0.47] and HR, 0.76 [95% CI, 0.71-0.82], respectively). Of 39 characteristics/categories considered, only participants aged ≥80 years were less likely to receive a transplant than those with severe obesity. Transplant recipients were followed for a median of 5.4 years. After those aged ≥65 years, participants with severe obesity were the most likely to experience allograft failure or death (HR, 1.70 [95% CI, 1.38-2.02] compared with controls). When we considered combinations of key risk factors, young participants with severe or moderate obesity and few comorbidities were at lower risk for allograft failure or death than participants with other common clinical characteristics.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Limitations&lt;/h3&gt;&lt;div&gt;Residual confounding.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Canadian dialysis patients with moderate or severe obesity had a markedly reduced likelihood of receiving a kidney transplant. Although patients with moderate or severe obesity also had a heightened risk of allograft failure or death, the magnitude of the latter was similar to the excess risk associated with other common clinical characteristics. These findings support current practice guidelines and suggest that further work should identify and remove barriers to accessing kidney transplantation among patients with obesity.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Plain-Language Summary&lt;/h3&gt;&lt;div&gt;International guidelines do not consider moderate or severe obesity (body mass index ≥35 and ≥40 kg/m&lt;sup&gt;2&lt;/sup&gt;, respectively) to be a contraindication to kidney transplantation, but clinical practice suggests otherwise. Canadian dialysis patients with moderate or severe obesity had a reduced likel","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"87 2","pages":"Pages 199-210"},"PeriodicalIF":8.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145516264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Kidney Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1